Fexapotide TFA
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) .
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog